The Perceptual Experience of Argus II Users
Predicting the Perceptual Experience of Argus II Retinal Prosthesis System Users
1 other identifier
interventional
6
1 country
3
Brief Summary
This Basic Experimental Studies Involving Humans (BESH) study investigates phosphene perception and performance factors in blind participants implanted with the Argus II retinal prosthesis system. Using paired-electrode stimulation, we analyze how phosphene shape and number are influenced by neuroanatomical factors, stimulus parameters, and spatial offsets. Additionally, we examine the causes of high current thresholds and limited spatial resolution, which impede pattern vision in Argus II devices. This research aims to provide insights for optimizing stimulation strategies and improving retinal prosthesis design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2022
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 11, 2022
CompletedFirst Submitted
Initial submission to the registry
February 4, 2022
CompletedFirst Posted
Study publicly available on registry
March 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedResults Posted
Study results publicly available
January 1, 2025
CompletedJanuary 1, 2025
December 1, 2024
1.6 years
February 4, 2022
November 27, 2024
December 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Phosphenes Perceived
Number of phosphenes perceived in response to paired-electrode stimulation across 5 spatial distances and 7 temporal interpulse delays. Phosphenes are brief sensations of light or visual flashes that occur in the absence of an external light source. A response is counted as a phosphene if the participant reports any visual sensation consistent with a flash of light.
during single-session testing
Study Arms (1)
Argus II users
EXPERIMENTALThis Basic Experimental Studies Involving Humans (BESH) study investigates phosphene perception and performance factors in blind participants implanted with the Argus II retinal prosthesis system. Using paired-electrode stimulation, we analyze how phosphene shape and number are influenced by neuroanatomical factors, stimulus parameters, and spatial offsets. Additionally, we examine the causes of high current thresholds and limited spatial resolution, which impede pattern vision in Argus II devices. This research aims to provide insights for optimizing stimulation strategies and improving retinal prosthesis design.
Interventions
Participants used the Argus II retinal prosthesis system in both experiments to perform visual perception tasks.
Eligibility Criteria
You may qualify if:
- Subject must be at least 25 years of age;
- Subject has been implanted with the Argus II system;
- Subject's eye has healed from surgery and the surgeon has cleared the subject for programming;
- Subject has the cognitive and communication ability to participate in the study (i.e., follow spoken directions, perform tests, and give feedback);
- Subject is willing to conduct psychophysics testing up to 4-6 hours per day of testing on 3-5 consecutive days;
- Subject is capable of understanding patient information materials and giving written informed consent;
- Subject is able to walk unassisted.
You may not qualify if:
- Subject is unwilling or unable to travel to testing facility for at least 3 days of testing within a one-week timeframe;
- Sighted controls: Subject has a history of motion sickness or flicker vertigo
- Subject does not speak English;
- Subject has language or hearing impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Santa Barbaralead
- Johns Hopkins Universitycollaborator
- University of Michigancollaborator
- National Eye Institute (NEI)collaborator
Study Sites (3)
University of California, Santa Barbara
Santa Barbara, California, 93106, United States
Johns Hopkins University
Baltimore, Maryland, 21287, United States
University of Michigan, Ann Arbor
Ann Arbor, Michigan, 48109, United States
Related Publications (2)
Yucel EI, Sadeghi R, Kartha A, Montezuma SR, Dagnelie G, Rokem A, Boynton GM, Fine I, Beyeler M. Factors affecting two-point discrimination in Argus II patients. Front Neurosci. 2022 Aug 24;16:901337. doi: 10.3389/fnins.2022.901337. eCollection 2022.
PMID: 36090266RESULTHou Y, Nanduri D, Granley J, Weiland JD, Beyeler M. Axonal stimulation affects the linear summation of single-point perception in three Argus II users. J Neural Eng. 2024 Apr 8;21(2):026031. doi: 10.1088/1741-2552/ad31c4.
PMID: 38457841RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michael Beyeler
- Organization
- University of California, Santa Barbara
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Beyeler, PhD
University of California, Santa Barbara
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 4, 2022
First Posted
March 17, 2022
Study Start
January 11, 2022
Primary Completion
August 31, 2023
Study Completion
August 31, 2023
Last Updated
January 1, 2025
Results First Posted
January 1, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Spring 2023 onward
- Access Criteria
- Any researchers with a legitimate reason for wishing to re-analyze the data or compare them to study data collected in similar experiments
Deidentified data will be available from the investigative team, following initial publication of the results